BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20251023T173248EDT-2184oNu652@132.216.98.100
DTSTAMP:20251023T213248Z
DESCRIPTION:Join D2R and CASTL for this hybrid Lunch and Learn about bioman
 ufacturing and RNA therapeutics\n\nIn this presentation\, D2R and CASTL wi
 ll connect the world of research with industrial applications! This Lunch 
 and Learn will provide a practical way introduce participants to how mRNA-
 LNP based biotherapeutics are manufactured\, and showcase opportunities an
 d career pathways in the biomanufacturing sector. \n\nAbout the Speaker\n
 \nSven Ansorge \n\nSven has more than 15 years of experience in biopharmac
 eutical industry and R&D. He holds a PhD in Chemical Engineering from Poly
 technique de Montréal and has led teams and projects within academic and i
 ndustrial/GMP manufacturing environments. He is specialized in bioprocessi
 ng for the production of viral vectors\, vaccines\, recombinant proteins a
 nd cell therapy products.His experience spans from small biotech (Enobia/A
 lexion\, ExCellThera) to large pharma (GSK\, Belgium) and from R&D/process
  development to commercial GMP manufacturing. Since 2022\, he works at the
  Canadian Alliance for Skills and Training in Life Sciences (CASTL). CASTL
  provides world-class technical skills development and training in life sc
 iences specializing in biopharmaceutical manufacturing. It is a unique par
 tnership between academia\, industry\, and government to address the futur
 e skills needs of the fast-growing bioscience sector. As Director of Techn
 ical Training\, Sven currently oversees technical training that CASTL prov
 ides through its training facilities in Charlottetown (PEI)\, Montreal (QC
 ) and Richmond (BC). Prior to joining CASTL\, he led the manufacturing and
  process development activities at ExCellThera (2019-2022)\, a clinical st
 age cell therapy company and contributed to developing a cell therapy prod
 uct towards commercial approval. From 2014-2019\, he was at the National R
 esearch Council Canada (NRC) where he built and managed a team focusing on
  scaling-up cell culture-based suspension processes. This included process
  development and technology transfer of upstream bioprocesses using multip
 le cell line platforms. One of the focus areas was the development of perf
 usion-based lentiviral vector production processes\, which Sven started to
  work on in 2006 as a PhD student under Amine Kamen’s supervision. Togethe
 r with collaborators and colleagues\, he has published more than 20 peer-r
 eviewed manuscripts and has presented at multiple international conference
 s. Since 2019\, he is an Adjunct Professor in the Department of Bioenginee
 ring at º£½Ç¾«Æ·ºÚÁÏ.\n\nRegister\n\nBe part of this exciting learnin
 g opportunity with industry!\n\nRegister here to receive the Zoom link\n\n
 For those attending in-person\, there will be a networking session with li
 ght refreshments following the presentation. Space is limited! \n\nReserve
  your spot today\n\nConfirmation emails will be provided to registered par
 ticipants a few days before the event.\n
DTSTART:20251106T170000Z
DTEND:20251106T183000Z
SUMMARY:Hybrid Event |  Lunch and Learn with CASTL
URL:/drs/channels/event/hybrid-event-lunch-and-learn-c
 astl-368313
END:VEVENT
END:VCALENDAR